David A. Morrow, M.D. and Elliott M. Antman, M.D.
Dr. Morrow is Fellow in Cardiovascular Medicine, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School. Dr. Antman is Associate Professor of Medicine, Harvard Medical School, Director, Coronary Care Unit, Brigham and Women's Hospital, Boston, MA.
Drs. Morrow and Antman report no commercial conflict of interest.
Estimated course time: 1 hour(s).
Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Upon completion of this Cyberounds®, you should be able to:
Describe the individual advantages and disadvantages of each of the major markers of myocardial necrosis in the diagnosis of acute myocardial infarction
Discuss the prognostic capacity of the cardiac specific troponins among patients with chest pain suspicious for myocardial infarction
Outline the potential future uses of novel cardiac markers in the evaluation, triage and treatment of patients with acute coronary syndromes.
